◆ 会议时间：2021年3月10日至12日
◆ 会议地点：虚拟会议
◆ 会议简介：
2021年北欧妇科肿瘤学会(NSGO)年会-虚拟会议将于2021年3月10日至12日举行.
北欧妇科肿瘤学会(NSGO)是一个非政治性、非营利性组织，其宗旨是为从事妇科癌症患者护理的专业人士提供一个交流学习的平台；致力于改善妇科癌症的预防、诊断、治疗和随访工作；促进和支持基础与临床研究；促进妇科肿瘤相关专业的教育与培训；促进和支持北欧与国际间的交流，与其他国际、国家和地区组织建立合作与联系；组织和协调会议与协作活动；制定北欧妇科癌症患者护理标准，制定北欧妇科肿瘤专业教育和培训指南；等等。——未经本站许可，禁止复制转载镜像本站任何内容—领域国际医学会议网。
Welcome to NSGO Virtual Annual Meeting 2021
NSGO welcomes all members and other professionals with interest in gynaecological cancer research to the NSGO Annual Meeting 2021. Pharmaceutical companies can only attend the meeting as Gold Sponsors or as Exhibitors.
The NSGO Annual Meeting is this year virtual from 10-12 March 2021.
The scientific program of this meeting focuses on Cervical cancer, New diagnostic and therapeutic methods, Quality and Patient perspective, and we are honored that the most prominent international faculty is joining our meeting. This year our Gold Sponsors and Exhibitors will on the meeting website have a separate link to enter the virtual exhibition hall. More information will follow. On the 10 and 11 March pharma-sponsored symposia will be held.
Instead of a poster exhibition, scientific work will this year be represented in form of oral presentation competition.
NSGO Annual Meeting administration fee includes participation in Annual Meeting, the NSGO-CTU Investigator Meeting and the Satellite Symposia. If you have already paid your membership fee for 2021, your membership payment will be transferred to 2022.
Deadline for registration for Annual Meeting is 8 March 2021.
Meeting administration fee (until 15 April 2021):
- Members who have paid their membership fee the previous year or new members (who has been approved): 1.875 DKK including membership fee 2021
- Members who have not paid their membership fee the previous year (2020): 2.250 DKK including membership fee 2021
- Members who have not paid their membership fee the two previous years (2019 and 2020): 2.625 DKK including membership fee 2021
- Non members: 3750 DKK
- Study nurses: 1375 DKK
◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。
|
